Advertisement

Picture Bionordic Nordic Life Science Days 2018 Stockholm 600x60px
Person › Details

John Allinson (Icon plc)

Allinson, John (Icon plc 201011 VP Biomarker Lab Services)

 

Organisation Organisation Icon plc
  Group Icon plc (Group)
Products Product biomarker discovery services
  Product 2 contract research, pre-clinical
     

Proteome Sciences plc. (11/15/10). "Press Release: Proteome Sciences and ICON Partner for the Delivery of Comprehensive Biomarker Solutions".

Proteome Sciences plc (AIM:PRM) a leading provider of protein biomarker discovery, validation, and assay development services, and, ICON plc, (NASDAQ:ICLR) (ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announce the formation of a strategic alliance to provide pharmaceutical companies with an expanded biomarker solution to allow earlier assessments in the development of new medicines.

Through the alliance with Proteome's PS Biomarker Services™, ICON is able to provide a strengthened biomarker solution to include Proteome Sciences' unique integrated suite of labeling, separation and mass spectrometry technologies for protein and peptide profiling in complex biological materials.

Proteome Sciences and ICON are already engaged in their first joint project which is the development of a mass spectrometry assay for a key biomarker for an international pharmaceutical development company.

Commenting on the initiation of this project, John Allinson, VP Biomarker Lab Services, ICON Development Solutions stated:

"We are extremely pleased to be entering this long-term partnership with Proteome Sciences which allows us to offer our clients access to state of the art protein and peptide profiling and rapid development of mass spectrometry assays through PS Biomarker Services&trade. This complements ICON's extensive portfolio of biomarker development and analysis services to help sponsors identify, implement and interpret the right biomarkers to inform their pre-clinical and clinical drug development."

Dr. Ian Pike, Proteome Sciences' Chief Operating Officer added:

"We are delighted to be partnering with the team at ICON Development Solutions to provide their clients with a complete biomarker solution, including PS Biomarker Discovery Services™ as part of wider clinical development programs. The unique power of our proprietary technology platforms to identify and validate key protein biomarkers of disease and response to treatment is clearly being recognised and used by the pharmaceutical industry."

   
Record changed: 2015-08-18

Advertisement

Picture [LSF] Life-Sciences-France.com – The Business Web Portal 600x80px


More documents for John Allinson


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture Bionordic Nordic Life Science Days 2018 Stockholm 600x60px




» top